Jordan
· Delayed Price · Currency is JOD HPIC Statistics
Total Valuation
Hayat Pharmaceutical Industries Co. has a market cap or net worth of JOD 23.94 million. The enterprise value is 20.50 million.
| Market Cap | 23.94M |
| Enterprise Value | 20.50M |
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | Apr 28, 2024 |
Share Statistics
Hayat Pharmaceutical Industries Co. has 9.50 million shares outstanding. The number of shares has increased by 3.55% in one year.
| Shares Outstanding | 9.50M |
| Shares Change (YoY) | +3.55% |
| Shares Change (QoQ) | -9.32% |
| Owned by Insiders (%) | 56.77% |
| Owned by Institutions (%) | n/a |
| Float | 1.43M |
Valuation Ratios
The trailing PE ratio is 8.42.
| PE Ratio | 8.42 |
| Forward PE | n/a |
| PS Ratio | 1.51 |
| PB Ratio | 0.84 |
| P/FCF Ratio | 55.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.37, with an EV/FCF ratio of 47.13.
| EV / Earnings | 6.96 |
| EV / Sales | 1.25 |
| EV / EBITDA | 4.37 |
| EV / EBIT | 5.73 |
| EV / FCF | 47.13 |
Financial Position
The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.12.
| Current Ratio | 4.47 |
| Quick Ratio | 3.03 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.73 |
| Debt / FCF | 7.87 |
| Interest Coverage | 28.68 |
Financial Efficiency
Return on equity (ROE) is 10.54% and return on invested capital (ROIC) is 7.27%.
| Return on Equity (ROE) | 10.54% |
| Return on Assets (ROA) | 6.53% |
| Return on Capital (ROIC) | 7.27% |
| Revenue Per Employee | 69,560 |
| Profits Per Employee | 12,480 |
| Employee Count | 236 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.21% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +1.21% |
| 50-Day Moving Average | 2.51 |
| 200-Day Moving Average | 2.49 |
| Relative Strength Index (RSI) | 48.93 |
| Average Volume (20 Days) | 571 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hayat Pharmaceutical Industries Co. had revenue of JOD 16.42 million and earned 2.95 million in profits. Earnings per share was 0.30.
| Revenue | 16.42M |
| Gross Profit | 10.09M |
| Operating Income | 3.58M |
| Pretax Income | 3.45M |
| Net Income | 2.95M |
| EBITDA | 4.69M |
| EBIT | 3.58M |
| Earnings Per Share (EPS) | 0.30 |
Balance Sheet
The company has 6.87 million in cash and 3.42 million in debt, giving a net cash position of 3.44 million or 0.36 per share.
| Cash & Cash Equivalents | 6.87M |
| Total Debt | 3.42M |
| Net Cash | 3.44M |
| Net Cash Per Share | 0.36 |
| Equity (Book Value) | 28.63M |
| Book Value Per Share | 3.01 |
| Working Capital | 17.52M |
Cash Flow
In the last 12 months, operating cash flow was 1.19 million and capital expenditures -750,679, giving a free cash flow of 434,910.
| Operating Cash Flow | 1.19M |
| Capital Expenditures | -750,679 |
| Free Cash Flow | 434,910 |
| FCF Per Share | 0.05 |
Margins
Gross margin is 61.45%, with operating and profit margins of 21.79% and 17.94%.
| Gross Margin | 61.45% |
| Operating Margin | 21.79% |
| Pretax Margin | 21.03% |
| Profit Margin | 17.94% |
| EBITDA Margin | 28.56% |
| EBIT Margin | 21.79% |
| FCF Margin | 2.65% |
Dividends & Yields
This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 6.55%.
| Dividend Per Share | 0.17 |
| Dividend Yield | 6.55% |
| Dividend Growth (YoY) | -34.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 53.22% |
| Buyback Yield | -3.55% |
| Shareholder Yield | 3.00% |
| Earnings Yield | 11.88% |
| FCF Yield | 1.82% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hayat Pharmaceutical Industries Co. has an Altman Z-Score of 4.16.
| Altman Z-Score | 4.16 |
| Piotroski F-Score | n/a |